Answer
The duration of protection provided by Spikevax JN.1 (mRNA-1273.167) is unknown and is still being determined by ongoing clinical trials.
Sources for this answer
- Spikevax JN.1 0.1 mg/mL dispersion for injectionModerna Biotech Distributor UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked